Infant Rotavirus Study
Participants needed: Healthy infants aged 6-12 weeks
Rotavirus (RV) infection is the leading cause of severely inflamed stomach or gut (gastroenteritis [GE]) and severe diarrhea in infants and young children less than 5 years of age. Over the last few decades, the development of vaccines has been beneficial to prevent deaths due to RV infection.
Purpose of the study:
The types of vaccines against Rotavirus infection currently manufactured by GSK are:
- Licensed Rotarix (lyophilized – freeze dried powder that is mixed with a liquid)
- PCV-free HRV vaccine (liquid)
- Licensed Rotarix (liquid)
In this study, GSK will compare the safety profile of the first 2 vaccines mentioned above in infants.
Is my child eligible to participate?
We are looking for healthy infants aged 6-12 weeks old to take part in this clinical research study.
Participation in the study involves 3 scheduled study visits over a 7-8 month. You will also be contacted once by a phone call or email by the study staff. No samples will be collected during the study.
The visits will occur at the Canadian Center for Vaccinology (CCfV) located at the IWK Health Centre. We estimate the total time commitment to participate in the study will be approximately 3-4 hours.
Contact Pam MacIntyre